A multicenter phase I trial of metronomic oral vinorelbine plus cisplatin in patients with NSCLC
β Scribed by Athanasios G. Pallis; Vassilis Chandrinos; Georgia Pavlakou; Nikolaos Xenidis; Ioannis Varthalitis; Nikolaos Vardakis; Lambros Vamvakas; Emmanouel Kontopodis; Maria Rovithi; Vassilis Georgoulias
- Publisher
- Springer
- Year
- 2010
- Tongue
- English
- Weight
- 291 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: The combination of uracil and tegafur in a 4:1 molar concentration (uft) has a greater antitumor activity than 5-fluorouracil (5-fu) and tegafur. because the combination of 5-fu and cisplatin has been proven to have a synergistic antitumor effect in many experimental and clinical stu
## Background: With preclinical evidence of synergy, this dose-finding trial examining the combination of docetaxel and vinorelbine given with prophylactic filgrastim for the treatment of patients with nonsmall cell lung carcinoma was undertaken. ## Methods: Twenty-seven patients with advanced no
## BACKGROUND. Both locoregional and distant disease control remains poor in the treatment of Stage III nonsmall cell lung carcinoma (NSCLC). This trial was conducted to evaluate the tolerance and responses of patients with NSCLC given a neoadjuvant regimen of cisplatin and vinorelbine chemotherapy